{"nct_id":"NCT06765954","title":"Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.","status":"NOT_YET_RECRUITING","status_verified_date":"2024-12","start_date":"2025-06-01","start_date_type":"ESTIMATED","primary_completion_date":"2031-01-31","primary_completion_date_type":"ESTIMATED","completion_date":"2031-06-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["IBRX"]}